Use the AQT in conjunction with brain imaging (e.g., CT scan, MRI) and other neuro-psychiatric procedures to support an early differential diagnosis of various types of dementia including Alzheimer’s Disease, Lewy body Disease, Parkinson’s Disease, and other neurological disorders. Elisabeth H. Wiig, a renowned language expert, and an esteemed group of leaders in neuropsychology, neuropsychiatry and gerontology teamed to develop AQT.
Use this test with confidence when assessing your clients!
- AQT contains rapid, automatic naming (RAN) tasks, verified by rCBF measures to screen for Alzheimer's disease and other parietal impairments.
- AQT tasks measure:
- Processing speed and automaticity of naming
- Cognitive shifts between visual dimensions and semantic fields
- Activation of working memory for processing and monitoring
- Parietal lobe dysfunction associated with neurogenic disorders.
- AQT’s objective measures are based on clocked total-naming time.
- Highly reliable (r = .88 – 96) over time and consistent over repeated trials.
- Independent of gender differences, education, and cultural-linguistic background
- Enables examiners from other cultural-linguistic communities to develop directions for administration and standards for verbal responses that are representative of their language.
- Conduct comparative evaluations of monolingual or bilingual adolescents and adults.
For additional information visit the author's web site at: www.parietal.org